Literature DB >> 30138943

Diagnosis, Prevention and Treatment of Stable COPD and Acute Exacerbations of COPD: The Swiss Recommendations 2018.

Daiana Stolz1, Jürg Barandun2, Heinz Borer3, Pierre-Olivier Bridevaux4, Patrick Brun5, Martin Brutsche6, Christian Clarenbach7, Christine Eich8, René Fiechter9, Martin Frey10, Thomas Geiser11, Michael Grob12, Erich Helfenstein13, Lilian Junker14, Malcolm Kohler7, Tsogyal Latshang15, Armin Lechmann16, Marc Maurer17, Laurent Nicod18, Franco Quadri19, Daniel Schilter20, Thomas Sigrist10, Paola Soccal21, Philip Tarr22, Robert Thurnheer23, Alexander Turk24, Michael Tamm1.   

Abstract

The Swiss National Guidelines 2013 for chronic obstructive pulmonary disease have been revised in order to acknowledge recent progress in diagnosis and management of this disease. The resulting new Swiss recommendations are based on best evidence from the literature, the Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2018 report and other published national guidelines. Misdiagnosis of chronic obstructive pulmonary disease is common and means that patients do not always receive optimal treatment. To improve the management of patients with chronic obstructive pulmonary disease in Switzerland, these recommendations encourage a more comprehensive assessment of patients, based on the combined assessment of symptoms, degree of airflow limitation, risk of exacerbation and the presence of comorbidities. Recommendations for evidence-based preventive measures, as well as pharmacological and non-pharmacological strategies for the management of both stable and acute exacerbations of chronic obstructive pulmonary disease are provided in this update.
© 2018 S. Karger AG, Basel.

Entities:  

Keywords:  Chronic obstructive pulmonary disease; Exacerbations; Recommendations; Swiss; Treatment; Update

Mesh:

Substances:

Year:  2018        PMID: 30138943     DOI: 10.1159/000490551

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  8 in total

1.  Development of primary care quality indicators for chronic obstructive pulmonary disease using a Delphi-derived method.

Authors:  Sigrid Dewaele; Steve Van den Bulck; Lien Gerne; Bert Vaes
Journal:  NPJ Prim Care Respir Med       Date:  2022-03-18       Impact factor: 2.871

2.  The association between cystatin C and COPD: a meta-analysis and systematic review.

Authors:  Limin Chai; Wei Feng; Cui Zhai; Wenhua Shi; Jian Wang; Xin Yan; Qingting Wang; Qianqian Zhang; Manxiang Li
Journal:  BMC Pulm Med       Date:  2020-06-26       Impact factor: 3.317

3.  Efficacy and safety of Jia Wei Bushen Yiqi formulas as an adjunct therapy to systemic glucocorticoids on acute exacerbation of COPD: study protocol for a randomized, double-blinded, multi-center, placebo-controlled clinical trial.

Authors:  Qing Kong; Shuming Mo; Wenqian Wang; Zihui Tang; Ying Wei; Yijie Du; Baojun Liu; Lingwen Kong; Yubao Lv; Jingcheng Dong
Journal:  Trials       Date:  2020-09-03       Impact factor: 2.279

4.  Rcn3 Suppression Was Responsible for Partial Relief of Emphysema as Shown by Specific Type II Alveolar Epithelial Cell Rcn3 CKO Mouse Model.

Authors:  Qianyu Zhang; Tong Wang; Jiawei Jin; Xiaoqian Shi; Aiben Huang; Zhenru Ma; Jiujie Li; Shiyu Wang; Runlin Z Ma; Qiuhong Fang
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-01-26

5.  Diagnostic Values of Blood Urea Nitrogen (BUN), Creatinine (Cr), and the Ratio of BUN to Cr for Distinguishing Heart Failure from Asthma and Chronic Obstructive Pulmonary Disease.

Authors:  Jingjing Zhang; Ling Zhou; Yuezhan Zhang
Journal:  Comput Math Methods Med       Date:  2022-07-21       Impact factor: 2.809

6.  Supporting Behavior Change After AECOPD - Development of a Hospital-Initiated Intervention Using the Behavior Change Wheel.

Authors:  Paul Chadwick; Christian Clarenbach; Gabriela Schmid-Mohler; Christine Hübsch; Claudia Steurer-Stey; Nico Greco; Macé M Schuurmans; Sonja Beckmann
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2022-07-26

7.  Application of Acupoint Catgut Embedding Therapy Combined with Liuzijue Breathing Exercise in the Treatment of Patients with Stable Chronic Obstructive Pulmonary Disease.

Authors:  Yun Zheng; Jing Xia; Jisheng Zheng
Journal:  Evid Based Complement Alternat Med       Date:  2022-10-06       Impact factor: 2.650

8.  Identification of smoking cessation phenotypes as a basis for individualized counseling: An explorative real-world cohort study.

Authors:  Maciej Paciorkowski; Florent Baty; Susanne Pohle; Esther Bürki; Martin Brutsche
Journal:  Tob Induc Dis       Date:  2022-09-23       Impact factor: 5.163

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.